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Background: Genetic variation in the ribosomal DNA (rDNA) internal transcribed spacer (ITS) region has been
studied among fungi. However, the numbers of ITS sequence polymorphisms in the various Candida species and
their associations with sources of invasive fungal infections remain poorly investigated. Here, we characterized the
intraspecific and interspecific ITS diversity of Candida spp. strains collected from patients with bloodstream or
oroesophageal candidiasis.
Methods: We selected cultures of representative medically important species of Candida as well as some rare and
emerging pathogens. Identification was performed by micromorphology and by biochemical testing using an
ID32C® system, as well as by the sequencing of rDNA ITS. The presence of intraspecific ITS polymorphisms was
characterized based on haplotype networks, and interspecific diversity was characterized based on Bayesian
phylogenetic analysis.
Results: Among 300 Candida strains, we identified 76 C. albicans, 14 C. dubliniensis, 40 C. tropicalis, 47 C. glabrata,
34 C. parapsilosis (sensu stricto), 31 C. orthopsilosis, 3 C. metapsilosis, 21 Meyerozyma guilliermondii (C. guilliermondii),
12 Pichia kudriavzevii (C. krusei), 6 Clavispora lusitaniae (C. lusitaniae), 3 C. intermedia, 6 Wickerhamomyces anomalus
(C. pelliculosa), and 2 C. haemulonii strains, and 1 C. duobushaemulonii, 1 Kluyveromyces marxianus (C. kefyr), 1
Meyerozyma caribbica (C. fermentati), 1 Pichia norvegensis (C. norvegensis), and 1 Lodderomyces elongisporus strain.
Out of a total of seven isolates with inconsistent ID32C® profiles, ITS sequencing identified one C. lusitaniae strain,
three C. intermedia strains, two C. haemulonii strains and one C. duobushaemulonii strain. Analysis of ITS variability
revealed a greater number of haplotypes among C. albicans, C. tropicalis, C. glabrata and C. lusitaniae, which are
predominantly related to endogenous sources of acquisition. Bayesian analysis confirmed the major phylogenetic
relationships among the isolates and the molecular identification of the different Candida spp.
Conclusions: Molecular studies based on ITS sequencing are necessary to identify closely related and emerging
species. Polymorphism analysis of the ITS rDNA region demonstrated its utility as a genetic marker for species
identification and phylogenetic relationships as well as for drawing inferences concerning the natural history of
hematogenous infections caused by medically important and emerging Candida species.
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Invasive candidiasis is recognized as a cause of morbidity
and mortality in tertiary care hospitals worldwide [1,2].
Although the majority of cases of invasive yeast infection
are attributed to Candida albicans, there are increasing
rates of infection by non-C. albicans species in various
parts of the world [2,3]. Conventional methods used by
reference centers for the identification of medically
important yeasts have been progressively replaced by
PCR-based methods and proteomics [4,5]. However, in
resource-limited settings, commercial biochemical tests
still represent the cornerstone for the identification of
human yeast pathogens [4]. These methods are usually
time-consuming and have potential limitations with
respect to the accurate identification of rare pathogens
and of cryptic species of Candida [6].
The establishment of DNA sequencing as a gold stand-
ard method for yeast identification by clinical laboratories
has been hindered by several factors, including its cost,
the lack of well-trained professionals [7], the limitations of
the currently accepted DNA barcode system for fungi [8],
and poor standardization of quality controls to ensure the
accuracy of molecular methods [9]. Other important is-
sues include the quality of reference nucleotide sequences
derived from well-characterized yeast collections depos-
ited in public genomic databases and the limited number
of fungal species, especially those related to human
infections, for which data are present in sequence data-
bases [10,11]. Nevertheless, progress in microorganism
genomics and its application to the taxonomy of fungal
pathogens has enabled an extensive review of several gen-
era and the recognition of cryptic species within formerly
recognized taxons, for example, the C. parapsilosis species
complex, the C. guilliermondii complex, the C. haemulonii
complex, C. rugosa and others [12-15]. Consequently,
there is a need to expand public nucleotide databases to
include sequences of emerging fungal pathogens [10,11].
Despite the limitations cited above, the utilization of the
ribosomal DNA (rDNA) internal transcribed spacer (ITS)
region for sequence analysis appears to be the most reli-
able strategy for the accurate and rapid molecular identifi-
cation of fungal pathogens that infect humans [16,17].
Furthermore, polymorphisms in the ITS region have been
extensively addressed in phylogenetic, taxonomic and
population dynamics studies and are particularly useful for
the delineation of Candida species and strains [16,18].
Haplotype analysis through the detection of single nu-
cleotide polymorphisms (SNPs) found in particular target
DNA sequences has been shown to be useful in the esti-
mation of the intraspecies genetic diversity of fungal spe-
cies, and this technique has also been used in population
genetics studies of fungi that cause human and animal
infections, permitting their evaluation from phylogenetic,
biogeographic and epidemiologic perspectives [19-21].Several molecular investigations characterizing the
frequency of outbreaks and nosocomial clusters in
patients with candidemia have been performed [22-25].
The methods used in these investigations have included
pulsed-field gel electrophoresis (PFGE), random ampli-
fication of polymorphic DNA (RAPD), analysis of re-
striction fragment length polymorphisms (RFLP), PCR
fingerprinting and multilocus sequence typing (MLST)
[26-28]. In this context, analysis of nosocomial cluster-
ing of candidemia may be useful for determining the
true frequency of exogenously acquired Candida infec-
tions transmitted to patients by the hands of caregivers
and by contamination associated with invasive medical
procedures.
In the present study, we aimed to determine the poten-
tial use of the rDNA ITS region as a molecular marker for
evaluating genetic diversity within and among clinically
important and emerging Candida species from a large
Brazilian yeast collection characterized by conventional
and molecular methods. The presence of intraspecific ITS
variability was characterized based on haplotype networks,
and Bayesian analysis was used to develop phylogenetic
inferences. The incorporation of ITS sequences of human
pathogenic Candida species into public nucleotide se-
quence databases and the reliability of ITS sequence data
were also addressed.
Methods
Selection of microorganisms
For this study, 300 strains of Candida spp. were selected
from the large yeast stock culture collection of the
Laboratório Especial de Micologia, Escola Paulista de
Medicina, Universidade Federal de São Paulo, Brazil. All
fungal isolates were collected between 1997 and 2011
during multicenter surveillance studies conducted at
Brazilian medical centers [1,29-31]. We selected cultures
of representative medically important species of Candida,
as well as cultures of some rare or emerging pathogens.
With the exception of C. dubliniensis strains (n = 14), which
were isolated from patients with oroesophageal infection,
all species (n = 286) were obtained from blood cultures
of patients with fungemia. In addition, the following 11
reference/type strains were included: C. albicans SC5314, C.
albicans ATCC 24433, C. glabrata ATCC 2001, C. lusitaniae
ATCC 66035, C. krusei ATCC 6258, C. tropicalis ATCC
13803, C. parapsilosis ATCC 22019, C. orthopsilosis ATCC
96141, C. metapsilosis ATCC 96143, C. guilliermondii CBS
566 and C. dubliniensis CBS 7987. The clinical isolates
and the reference/type strains were identified simultan-
eously using phenotypic and molecular methods. In
addition to the nucleotide sequences of the reference/type
strains obtained and described above, the sequences of the
following eight strains were used for haplotype and phylo-
genetic analyses: Lodderomyces elongisporus ATCC 11503
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60480 (GenBank accession number: GU256755.1),
C. pelliculosa CBS 606 (MycoBank accession number:
346023), C. fermentati CBS 2022 (GenBank accession
number: EU568913.1), C. norvegensis CBS 2128 (GenBank
accession number: AB278167.1), C. intermedia WM 811
(GenBank accession number: EF568011.1), C. haemulonii
CBS 10970 (GenBank accession number: JX459674.1) and
C. duobushaemulonii CBS 7798 (GenBank accession num-
ber: JX459666.1). This work was approved by the institu-
tional board on ethics in research of the Universidade
Federal de São Paulo, Brazil (CEP008/11).
Conventional identification of Candida species
Cultures of Candida spp. stored at -80°C were plated on
CHROMagarTM Candida (CHROMagar Microbiology,
Paris, France) prepared according to the manufacturer’s
instructions for 48 h at 37°C to obtain pure colonies and
for presumptive identification of Candida spp. Slide cul-
tures on cornmeal agar medium with 1.2% Tween 80 were
prepared to evaluate the presence of chlamydoconidia,
blastoconidia and pseudohyphae. The ability to grow on
Difco™ Sabouraud Dextrose Agar (SDA) (Becton Dickin-
son & Co. Sparks, MD, USA) plates at 42°C after 48 h of
culture [32] or on hypertonic Sabouraud broth at 37°C for
96 h was used to discriminate between C. albicans and
C. dubliniensis [32,33]. Reference strains of C. albicans
(ATCC 24433) and C. dubliniensis (CBS 7987) were used
as controls. With the exception of C. albicans and
C. dubliniensis, the biochemical profiles of all Candida
species were evaluated using a commercial ID32C® system
according to the manufacturer’s instructions (bioMérieux,
Marcy-l’Étoile, France).
Molecular identification of Candida species by sequencing
of rDNA ITS
Total genomic DNA was extracted from the Candida
isolates using PrepMan® Ultra Sample Preparation Re-
agent (Applied Biosystems, Inc., Foster City, CA, USA)
according to the manufacturer’s instructions. PCR for
the amplification of the ITS region was performed using
the forward primer V9G (5′-TTACGTCCCTGCCCTT
TGTA-3′) and the reverse primer LS266 (5′-GCATT
CCCAAACAACTCGACTC-3′) [34]. The total length of
the amplified product was approximately 924 base pairs
for C. albicans. A total reaction volume of 25 μl contain-
ing 40 ng/ml of genomic DNA, 10 pmol/μl of each pri-
mer, and PCR Master Mix with 50 units/ml of Taq DNA
polymerase, 3 mM MgCl2, 400 μM dNTPs (Promega,
Madison, WI, USA), and sterile water were used for the
PCR reactions, which were performed in a Veriti 96-well
Thermal Cycler (Applied Biosystems, Inc., Foster City,
CA, USA) under the following conditions: an initial
denaturation step at 94°C for 5 min, 35 cycles ofdenaturation at 94°C for 1 min, annealing at 56°C for 30 s,
and extension at 72°C for 2 min, and a final extension step
at 72°C for 10 min. Positive (DNA from C. albicans ATCC
24433) and negative (sample lacking DNA) controls were
included in all assays. The amplicons were verified by
electrophoresis at 90 volts in 1% agarose/SYBR® Safe
DNA Stain (Invitrogen, Carlsbad, CA, USA) gels and
photographed using a UV transilluminator.
PCR products were subjected to dideoxynucleotide
sequencing with a Big Dye Terminator Reaction Kit v3.1
(Applied Biosystems, Inc., Foster City, CA, USA), using
the forward primers V9G and ITS1 (5′-TCCGTAGGTG
AACCTGCGG-3′) and the reverse primers LS266 and
ITS4 (5′-TCCTCCGCTTATTGATATGC-3′) [34,35] ac-
cording to the manufacturer’s instructions. After purifica-
tion and denaturation, the samples were run on an
automated ABI 3130 genetic analyzer (Applied Biosystems,
Inc., Foster City, CA, USA). For the sequencing reactions,
a total of six sequences were used, including three
forward strands (one strand sequenced with V9G and
two with ITS1) and three reverse strands (one strand se-
quenced with LS266 and two with ITS4) for each strain
to increase confidence in the sequencing data for the
detection of nucleotide polymorphisms and to avoid
experimental artifacts.
Consensus sequence assembly and editing were per-
formed using the programs Phred/Phrap and the sequence
editor Consed [36-38]. The error probability for each
called base was assessed, considering a Phred score > 40,
which was associated with a base call accuracy of 99.99%.
High-quality consensus sequences were obtained for ana-
lysis with assembly errors of less than one per 100 base
pairs after editing. The consensus sequences obtained in
our study were aligned and compared with sequences
deposited in public genomic databases (GenBank, NCBI,
USA and CBS database, the Netherlands). To ensure the
high accuracy of the results obtained using the nucleotide
sequence alignment tools, an e-value of less than 10-5 and
a maximum identity of equal to or higher than 98% were
considered for the correct identification of Candida at the
species level.
Analysis of intraspecific and interspecific diversities of ITS
sequences of Candida spp.
Haplotype analysis was conducted to assess the ITS intra-
specific variability of the Candida species. In the present
study, a haplotype was defined as a unique combination of
SNPs along a sequence, i.e., each different sequence in an
alignment. The ITS sequences of the Candida spp. were
aligned and edited using the muscle algorithm imple-
mented in SEAVIEW program 4.2.12 [39], excluding 18S
and 28S rDNA. The complete ITS sequences, including
ITS1 and ITS2 and the 5.8S region of rDNA were sub-
jected to sequence polymorphism analysis using DnaSP
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number of haplotypes (Hap), variable sites, haplotype
diversity (Hd), and nucleotide diversity (Pi) [41]. In brief,
haplotype diversity is a measure of the occurrence of a sin-
gle haplotype in a given species, considering the number
of sequences analyzed and the total number of haplotypes
found. Values range from 0 to 1, with those closer to 1 in-
dicating higher variability. Nucleotide diversity is a meas-
ure of the average number of nucleotide differences per
site between two sequences. Haplotype 1 corresponded
with the reference or type strain of each Candida spp.
For the ITS haplotype network, a total of 319 DNA
sequences of clinical (n = 300) and reference/type strains
(n = 19) comprising 17 Candida species and 1 non-Can-
dida species (Lodderomyces elongisporus) were aligned.
The haplotype network file (Roehl data file) was created
using DnaSP v.5.10 software, considering gaps. The
network was generated by the median-joining method
[42] using Network v4.612 software (http://www.fluxus-
engineering.com/).
To analyze the conservation of phylogenetic relation-
ships among the different Candida species, sequences rep-
resentative of each haplotype (Additional file 1: Table S1)
and the reference sequence found in the comparisons with
the public genomic databases were aligned and edited
using the muscle algorithm implemented in SEAVIEW
program 4.2.12 [39] and considering only the ITS1-ITS2
and 5.8S-rDNA regions. Phylogenetic inference was per-
formed using MrBayes 3.02 [43] with the default priors as
input and was run twice with four chains. The number of
generations was 2 million, and data were saved every 100
generations along with the GTR (general time reversible)
model, the shape of the gamma distribution parameters,
and the proportions of invariant sites estimated during the
run. Bootstrap analysis was conducted by evaluating 1,000
pseudoreplicates of the alignment with SEAVIEW program
4.2.12 [39] using the neighbor-joining method.
Nucleotide sequence accession numbers
The rDNA ITS sequences of the clinical strains of Candida
spp. and Lodderomyces elongisporus were deposited in the
GenBank database with the accession numbers KC408939
to KC408999. For complete information including strain
name, species name and accession numbers, see Additional
file 1: Table S1.
Results
In the present study, one hundred percent concordance
between the phenotypic and molecular methods was
obtained for a collection of clinically important yeast
isolates containing representative numbers of strains
(≥ 40 strains) as follows: C. albicans (n = 76), C. tropicalis
(n = 40) and C. glabrata (n = 47) (Additional file 2:
Table S2). Growth tests in hypertonic broth and at42°C allowed for the presumptive identification of 14
C. dubliniensis and 76 C. albicans isolates, and ITS
sequencing confirmed the identification of these two
species, indicating 100% concordance (Additional file 2:
Table S2). As expected, among 69 isolates phenotypic-
ally identified as C. parapsilosis (sensu lato), ITS se-
quencing distinguished 34 C. parapsilosis (sensu stricto),
31 C. orthopsilosis and three C. metapsilosis isolates and
one Lodderomyces elongisporus isolate. A total of 22 iso-
lates were identified as C. guilliermondii by biochemical
tests, while DNA sequence analysis detected 21 Meyero-
zyma guilliermondii (teleomorph of C. guilliermondii)
isolates and one Meyerozyma caribbica (teleomorph of
C. fermentati) isolate.
Seven isolates that exhibited inconclusive results based
on the ID32C® system were identified by ITS sequencing as
C. lusitaniae (n = 1), C. intermedia (n = 3), C. haemulonii
(n = 2) and C. duobushaemulonii (n = 1). Of six isolates
identified as C. lusitaniae by molecular methods, one showed
an inconsistent profile with the biochemical test. ITS
sequencing distinguished species within the C. haemulonii
complex, including two C. haemulonii isolates and one
C. duobushaemulonii isolate (see Additional file 2: Table S2).
The presence of sequence polymorphisms along the
total fragment length of the ITS rDNA (ITS1 and ITS2,
including the 5.8S region) was analyzed in clinically im-
portant Candida species with representative numbers of
strains (> 20 strains), as illustrated in Figure 1. A com-
parison of the ITS sequences of the clinical strains to
the sequence of the reference or type strain of each
Candida species revealed that nucleotide sequence
variability per site was increased in ITS1 compared with
ITS2. Five polymorphic sites in ITS1 and three in ITS2
were identified for C. albicans in addition to five varia-
tions in ITS1 and five in ITS2 for C. tropicalis, 13 in
ITS1 and seven in ITS2 for C. glabrata, one in ITS1
for C. parapsilosis (sensu stricto), six in ITS1 and one in
ITS2 for C. orthopsilosis, and one in ITS2 for M. guillier-
mondii. Sequence variations in the 5.8S region were
detected only for C. albicans (one site) and C. tropicalis
(one site).
Based on the results of rDNA ITS sequence analysis, we
also determined the presence of intraspecific variability in
the Candida species, of which three or more strains were
analyzed and compared to type/reference strains (Table 1).
High intraspecific variation was found for C. albicans,
C. tropicalis, C. glabrata, C. metapsilosis, P. kudriavzevii,
C. lusitaniae and C. intermedia, as evidenced by the
large numbers of haplotypes and variable sites and haplo-
type (Hd = 0.6179 to 0.8571) and nucleotide (Pi = 0.00164
to 0.02815) diversity. It is worth mentioning that
C. lusitaniae showed the highest haplotype diversity
(Hd = 0.8571) despite the low number of isolates of
this species (n = 6). The measurement of nucleotide
Polymorphic site (bp)
A B C
D E F
Figure 1 Analysis of nucleotide sequence variation of rDNA ITS in medically important Candida spp. Polymorphic sites in ITS1-5.8S-ITS2
rDNA were evaluated along the total sequence lengths for the following species for the assessment of the percentage of nucleotide variation
per site, for which the sequences of the clinical strains were compared with the sequence of the reference or type strain for each species:
(A) C. albicans (447 bp, 78 sequences), (B) C. tropicalis (437 bp, 41 sequences), (C) C. glabrata (803 bp, 48 sequences), (D) C. parapsilosis
(sensu stricto) (430 bp, 35 sequences), (E) C. orthopsilosis (426 bp, 32 sequences), and (F) M. guilliermondii (516 bp, 22 sequences).
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site in C. intermedia (Pi = 0.02815) and C. lusitaniae
(Pi = 0.02605) than in the other species tested.
On the other hand, minor intraspecific variations were
observed among isolates of C. parapsilosis (sensu stricto)
(Hd = 0.2924 and Pi = 0.00068), C. orthopsilosis (Hd = 0.4456
and Pi = 0.00083), and M. guilliermondii (Hd = 0.4848 and
Pi = 0.00094). Another interesting finding was the presence
of only one ITS haplotype for each of Wickerhamomyces
anomalus (n = 7) and C. haemulonii (n = 3), as demon-
strated by the lack of polymorphic sites and haplotype
and nucleotide diversities in these species.
The ITS haplotype network constructed by the align-
ment of 319 sequences (317 sequences of Candida spp.
and 2 L. elongisporus sequences) showed the presence of
67 haplotypes (Figure 2A). At a total of 873 sites
analyzed, we found 716 variable positions (Hd = 0.9556),
considering sites with gaps. Notable genetic diversity
was observed, as demonstrated by the large numbers
of haplotypes in clinically relevant species and in
some rare species of Candida, including 12 C. albicans
(n = 78), 9 C. tropicalis (n = 41), 11 C. glabrata (n = 48),5 P. kudriavzevii (n = 13), 5 C. lusitaniae (n = 7) and 3
C. intermedia haplotypes (n = 4). In contrast, only 2 haplo-
types each were found for C. parapsilosis (sensu stricto)
(n = 35), C. dubliniensis (n = 15) and M. guilliermondii
(n = 22), and only 1 haplotype each was found for
W. anomalus (n = 7) and C. haemulonii (n = 3). With re-
spect to acquisition sources ofCandida infection (Figure 2B),
high ITS diversity was found among species predomin-
antly associated with endogenous sources of infection
(C. albicans, C. tropicalis, C. glabrata and C. lusitaniae),
while low genetic diversity was observed in species predom-
inantly related to exogenous infection sources (C. parapsilosis
species complex, M. guilliermondii andW. anomalus).
Bayesian analysis (Figure 3) confirmed the molecular
identification of and the major phylogenetic relation-
ships among the various Candida spp. isolates, with high
posterior probabilities and bootstrap values in the
branches. Intraspecies variation was also observed within
the clades, demonstrating the conservation of the haplo-
types described herein.
In our study, large numbers of ITS sequences were
generated based on quality control criteria designed to
Figure 2 Genetic diversity of medically important and emerging Candida spp. based on rDNA ITS sequences. (A) The median-joining
haplotype network of 319 DNA sequences of clinical (n = 300) and reference/type strains (n = 19) belonging to 17 Candida species and 1
non-Candida species (Lodderomyces elongisporus). Each circle represents one haplotype (H1-H67), and the circle circumference is proportional
to the haplotype frequency of the dataset. The black dots (median vectors, m) represent unsampled or extinct haplotypes in the population.
Mutational steps are represented by lines between haplotypes and, in cases of long branches, by values. (B) The haplotypes are color-coded,
and each color represents the predominantly associated source of acquired infection for the haplotype (endogenous versus exogenous).
Table 1 Analysis of intraspecific variability of rDNA ITS sequences for clinically important and emerging Candida
species
Candida species Number ofsequences
Sequence length
(base pair)
Number of
haplotypes
Haplotype
diversity*
Number of variable
sites (ITS1-5.8S-ITS2)
Nucleotide
diversity** (Pi)
Candida albicans 78 447 12 0.7802 9 0.00190
Candida dubliniensis 15 454 2 0.1333 6 0.00088
Candida glabrata 48 803 11 0.6179 20 0.00290
Candida tropicalis 41 437 9 0.7500 11 0.00182
Candida parapsilosis (sensu stricto) 35 430 2 0.2924 1 0.00068
Candida orthopsilosis 32 426 3 0.4456 7 0.00083
Candida metapsilosis 3 443 3 0.8333 8 0.00830
Meyerozyma guilliermondii*** 22 516 2 0.4848 1 0.00094
Pichia kudriavzevii*** 13 421 5 0.7821 4 0.00164
Clavispora lusitaniae*** 7 299 5 0.8571 17 0.02605
Candida intermedia 4 302 3 0.8333 18 0.02815
Wickerhamomyces anomalus*** 7 523 1 0 0 0
Candida haemulonii 3 286 1 0 0 0
*The haplotype diversity is a measure of the presence of a single haplotype in a given species, considering the number of sequences analyzed and the total
number of haplotypes found. This parameter varies from 0 to 1, with values of closer to 1 indicating higher variability.
**The nucleotide diversity (Pi) is a measure of the average number of nucleotide differences per site between two sequences.
***Meyerozyma guilliermondii = teleomorph of Candida guilliermondii, Pichia kudriavzevii = teleomorph of Candida krusei, Clavispora lusitaniae = teleomorph of
Candida lusitaniae, and Wickerhamomyces anomalus = teleomorph of Candida pelliculosa.
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Figure 3 Unrooted Bayesian consensus phylogenetic tree of rDNA ITS haplotype representatives of Candida spp. Species names were
identified according to anamorphic nomenclature. Posterior probabilities and bootstrap values are depicted in the main nodes (pp/bootstrap).
The Bayesian tree was inferred from 2 million generations with a 50% burn-in, and runs were saved every 100 generations. The average standard
deviation of the split frequencies was 0.008203. The selected model was fA = 0.274572, fC = 0.203973, fG = 0.223583, and fT = 0.297972 with the
rate matrix [A–C] = 0.151397, [A–G] = 0.142740, [A–T] = 0.199583, [C–G] = 0.112413, [C–T] = 0.269359 and [G–T] = 0.124502. The shape parameter of
the gamma distribution was alpha = 1.517708, and the proportion of invariant sites was I = 0.196504.
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tify the Candida isolates at the species level. The quality
control criteria included PCR controls, the use of tripli-
cate reactions with both DNA strands for sequencing,
the estimation of assembly errors for high-quality
consensus sequences, and BLAST search parameters.
We deposited 60 ITS sequences of the most important
fungal pathogens and rare or emerging pathogens, in-
cluding 17 Candida species and 1 non-Candida species
(Lodderomyces elongisporus), in the NCBI database
(GenBank, USA). Fifty-eight ITS sequences, comprising
the sequences of all Candida species and L. elongisporus
submitted to GenBank, were deposited in the ISHAM-
ITS reference database, which can be accessed at http://
www.isham.org or at http://its.mycologylab.org.
Discussion
The accurate identification of Candida spp. is essential for
selecting the most effective therapeutic strategies to con-
trol invasive fungal infections caused by these species [7].
Here, the phenotypic methods used performed well in
identifying clinically important Candida species, including
C. albicans, C. tropicalis, the C. parapsilosis complex and
C. glabrata. However, the ID32C® system failed to identify
one C. lusitaniae isolate, three C. intermedia isolates and
three isolates belonging to the C. haemulonii species com-
plex. Some limitations of conventional methods have been
described for discrimination between C. lusitaniae and the
closely related species C. pulcherrima [44]. Conventional
identification of the C. haemulonii species complex is
still limited, however, because it is not included in
the database of current commercial biochemical sys-
tems, such as ID32C® [6]. Nevertheless, the reliable
identification of rare and emerging Candida species
that cause hematogenous infection, such as C. lusitaniae,
C. intermedia and the C. haemulonii complex, was
possible using DNA sequencing, corroborating with the
results presented by other authors [6,44,45].
For epidemiological or diagnostic purposes, DNA-based
methods have been used to differentiate the species form-
ing the C. parapsilosis complex [46]. Out of a total of 69
isolates phenotypically identified as C. parapsilosis (sensu
lato), 34 were determined to be C. parapsilosis (sensu
stricto), 31 were found to be C. orthopsilosis, three were
found to be C. metapsilosis and one was determinedto be Lodderomyces elongisporus by ITS sequencing.
Lodderomyces elongisporus was initially described as a tele-
omorph of C. parapsilosis [47]. Although L. elongisporus is
considered to be an uncommon cause of human disease,
isolates have been identified by DNA sequence analysis of
some clinical sources [6,48]. M. guilliermondii is also
currently considered to comprise a complex formed
by Debaryomyces hansenii (teleomorph of C. famata),
M. caribbica, C. carpophila and C. xestobii [13], which can
be differentiated by molecular methods, including sequen-
cing of the ITS and D1/D2 rDNA regions [49]. Here, we
found one isolate of M. caribbica by sequence analysis,
whereas only M. guilliermondii isolates were detected by
biochemical testing.
We also investigated intraspecific rDNA ITS polymor-
phisms of isolates from 17 Candida species and 1 non-
Candida species (Lodderomyces elongisporus). Some au-
thors have addressed the degree of variability within the
rDNA ITS region among fungi and have also observed
higher intraspecific diversity within the ITS1 region than
within the ITS2 region [50,51]. Based on haplotype
and network analysis, a high intraspecific variability of
ITS sequences was observed in species that primarily
represent endogenous sources of infection, including
C. albicans, C. tropicalis, C. glabrata and C. lusitaniae
[2]. Species with high genetic diversity are most fre-
quently human commensals, and this finding could
explain the existence of additional genetic adaptation
within normal microbiota with older evolutionary ori-
gins. Although the natural mode of reproduction of
C. albicans is known to be clonal, other mechanisms
that increase the genetic variability of this species could
occur, including recombination [52,53]. Pfaller et al. [54]
have tested 47 C. lusitaniae isolates, obtaining 28 differ-
ent karyotype profiles and 25 different types of restric-
tion endonuclease analysis of genomic DNA (REAG)
profiles. Our data confirm the great diversity among
C. lusitaniae haplotypes, possibly indicating the exist-
ence of a non-clonal form of propagation. In contrast,
less intraspecific variation was observed in the isolates
of C. parapsilosis and C. orthopsilosis, in which the
primary mode of infection is thought to be exogenous
[55]. Previous studies have shown a lower sequence
variability of C. parapsilosis (sensu stricto) compared
with C. orthopsilosis and C. metapsilosis isolates [56,57].
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W. anomalus isolates. Barchiesi and colleagues [58] have
studied 46 clinical isolates of W. anomalus using RFLP
and RAPD and have found that all of these isolates pro-
duce similar band patterns. The lack of ITS variability of
W. anomalus strains could be explained by the small
number of sequenced isolates (n = 6), by possible clonal
origin or even by a low mutation rate of the gene se-
lected in our present study. In contrast with species that
are more prevalent as human commensal organisms,
other Candida species, such as the C. parapsilosis com-
plex, M. guilliermondii and W. anomalus, have been
reported to be exogenous organisms that have been
isolated from environmental sources (plants, soil, in-
sects, and food), medical devices (central venous cath-
eter and parenteral nutrition), or the hands of health
care workers [2,55,59,60]. Although they are considered
to be rare causative agents of fungemia, W. anomalus
and M. guilliermondii have been associated with the oc-
currence of nosocomial outbreaks and pseudo-outbreaks,
respectively, especially in pediatric intensive care units
[61,62]. Species with low genetic variability that are more
often associated with exogenous transmission could be
less well adapted to human hosts, may predominantly
undergo clonal reproduction, and might have recently
diverged during their evolutionary histories [12,58,63].
In the present study, despite the limitation conferred by
the use of only one genetic marker to estimate intraspe-
cific diversity, it was possible to use the ITS haplotype
network to identify remarkable genetic polymorphisms
among clinical isolates comprising 17 Candida species. Of
course, the accuracy of haplotype analysis is influenced by
the molecular markers selected as well as by the number
of strains in the database and the network methods used
[64]. Importantly, all of the ITS sequences used for the
evaluation of intraspecific genetic variation were gener-
ated by the direct sequencing of PCR products. The
provision of reliable ITS sequences was based on quality
control criteria that were applied from PCR to sequence
analysis, for example, the amplification of products with
a total length that included the entire ITS region, the
use of a cut-off number of sequences to generate the
consensus sequence for each strain, and the use of well-
established computational tools for sequence assembly
and editing.
Recent molecular epidemiological surveys aiming to as-
sess genetic relationships among strains and temporal and
geographic distributions of clustered isolates as well as to
identify outbreaks and the recurrence of BSIs investigated
the occurrence of the nosocomial clustering of candidemia
caused by the most prevalent species of Candida [23,25].
Using PCR fingerprinting, a population-based study con-
ducted in Iceland has shown that 18.7% to 39.9% of
all cases of candidemia are nosocomial clusters primarilycaused by C. albicans, C. tropicalis and C. parapsilosis
[23]. In a recent epidemiologic study conducted by
Maganti and colleagues [25], nosocomial clusters have
been shown to represent 33% of total isolates causing
candidemia in Canadian hospitals. Using MLST analysis,
the genetic relatedness of Candida isolates has been
assessed in two Brazilian studies of candidemia, in
which different clusters have been found among isolates
of C. albicans [24] and C. tropicalis [65]. Our present
study reinforces the utility of sequence polymorphism
analysis for evaluating the relationships among Candida
species and its application for examining the molecular
epidemiology of fungal diseases.
Comparative analysis of our Candida ITS sequences
with those deposited in public genomic databases allowed
for the definition of appropriate quality parameters for use
with the sequence alignment search tools of the NCBI and
CBS databases, as demonstrated by the high identities of
our sequences at the species level to the sequences in the
nucleotide repositories. However, some caution must be
exercised with respect to species identification using DNA
sequencing because several factors may influence the
accuracy of this molecular assay, including the method-
ologies and programs used for sequence analysis and
the limited number of representative pathogenic fungal
species deposited in genomic databases, which may in-
clude incomplete sequences as well as errors in species
nomenclature. Analysis of the ITS sequence regions of
different taxonomic groups revealed that up to 20% of
sequences deposited in GenBank may contain errors in
species identification and/or outdated nomenclature
and may lack descriptive and updated annotations [10].
Conclusions
In conclusion, although conventional methods can be used
to reliably identify the most common Candida species,
molecular studies based on ITS sequencing are necessary
for the identification of closely related and emerging spe-
cies. DNA sequence polymorphisms, especially those ob-
served in ITS1, were more likely to be found in Candida
species primarily involved in endogenously acquired infec-
tions. Thus, C. albicans, C. tropicalis, C. glabrata and C.
lusitaniae showed high genetic diversity, while species
predominantly associated with exogenously acquired in-
fections, such as C. parapsilosis, M. guilliermondii and
W. anomalus, showed low intraspecific variability. In
addition, our findings indicate the importance of generat-
ing accurate ITS sequence regions based on quantitative
parameters, such as those used in this study. The use of
this criterion may help to increase the number of good-
quality DNA sequences of Candida species deposited in
public genomic databases, ensuring reliable information
for future studies involving the epidemiological, clinical
and molecular characterization of opportunistic fungi.
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